Test Price
2,800 AED✅ Home Collection Available
PRRT2 Gene (Benign Familial Infantile Seizures Type 2) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Genetic Counseling by a DHA-licensed medical geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The PRRT2 Gene NGS Test detects pathogenic variants associated with benign familial infantile seizures type 2 (BFIS2), a self-limiting autosomal dominant epilepsy syndrome. Using whole-gene Next-Generation Sequencing (NGS) with >99% coverage of coding exons ±10 bp splice junctions, this test provides superior variant detection compared to targeted genotyping.
| Feature | Our Test (PRRT2 NGS) | Closest Alternative (Single-Gene PCR) |
|---|---|---|
| Precision | 99.9% sensitivity; detects SNVs, indels, CNVs across entire coding region | Limited to known hot-spot mutations; may miss rare or novel variants |
| Method | NGS (Illumina platform), validated per ISO 9001:2015 | Allele-specific PCR; lower analytical performance |
| Speed | Report in 3–4 weeks | 2–3 weeks (but compromised clinical utility) |
Physician Insight & Safety Protocols
“The PRRT2 gene test provides definitive diagnostic clarity for familial infantile seizures. However, a negative result does not exclude other epileptic syndromes, and all findings must be interpreted within the full clinical context. Genetic counseling is essential before and after testing to ensure informed decision-making and appropriate management.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory & Safety Precautions
Do not discontinue prescribed antiepileptic medication without consulting your child's neurologist. Seizure medications should never be altered based solely on a genetic test result. Always follow your physician's guidance.
Exclusion Criteria & Emergency Red Flags
- This test is not indicated for acute seizure management or status epilepticus—seek immediate emergency care.
- Infants with fever, meningitis, or metabolic crises must be stabilized before sample collection.
- ER Red Flags: Prolonged seizure >5 minutes, breathing difficulty, loss of consciousness, or bluish skin—call 998 immediately.
Patient FAQ & Clinical Guidance
1. What is the PRRT2 gene test, and why is it needed for my infant?
The PRRT2 gene test uses next-generation sequencing to detect mutations that cause benign familial infantile seizures type 2, offering a definitive diagnosis for early-onset epilepsy. This information helps guide treatment decisions and family planning.
2. What sample is required, and how is the home collection arranged?
We require 2–3 mL of whole blood in an EDTA tube, a dried blood spot on an FTA card, or pre-extracted DNA. A certified phlebotomist will visit your home between 8 AM and 11 PM, with temperature-controlled transport to our laboratory.
3. How long will results take, and will a doctor explain them?
The laboratory issues a comprehensive clinical report within 3–4 weeks. A DHA-licensed medical geneticist will provide a telephonic explanation of your child's results and discuss any recommended follow-up steps.
UAE Regulatory & Data Privacy Adherence
- DHA Facility License: 1143 (Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE)
- Corporate Lab Branding: DNA Labs UAE
- Data Protection: Compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Medical Liability: Adheres to Federal Decree-Law No. 4 of 2016 on Medical Liability for clinical testing safety and patient consent.
- Accreditation: ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | PRRT2 Gene (Benign Familial Infantile Seizures Type 2) Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA tube), dried blood spot (FTA card), or pre-extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) – Illumina platform, whole-gene analysis |
| ICD-10-CM Code | G40.89, Z82.0, Z13.85 |
| LOINC Code | 92238-4 |
| DHA Facility License & Laboratory Address | License #1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians